Simulation offers a simple and flexible way to estimate the power of a clinical trial when analytic formulae are not available. The computational burden of using simulation has, however, restricted its application to only the simplest of sample size determination problems, often minimising a single parameter (the overall sample size) subject to power being above a target level. We describe a general framework for solving simulation-based sample size determination problems with several design parameters over which to optimise and several conflicting criteria to be minimised. The method is based on an established global optimisation algorithm widely used in the design and analysis of computer experiments, using a non-parametric regression mod...
The objective of non-inferiority trials is to demonstrate the efficiency of a novel treatment whethe...
Sample sizes for randomized controlled trials are typically based on power calculations. They requir...
Simultaneous modelling of dense and sparse pharmacokinetic data is possible with a population approa...
Simulation offers a simple and flexible way to estimate the power of a clinical trial when analytic ...
Background and objectives: A justifiable sample size is essential at trial design stage. Generally t...
While planning clinical trials, when simple formulas are unavailable to calculate sample size, stati...
Abstract Background Estimating the required sample size and statistical power for a study is an inte...
AbstractThe designer of a clinical trial needs to make many assumptions about real-life practice bas...
Basic methods to compute required sample sizes are well understood and supported by widely available...
Determining the optimal sample size is crucial for any scientific investigation. An optimal sample s...
What is the optimal size of an experiment? How should the practical experimenter determine this opti...
BACKGROUND: Stepped wedge trials (SWTs) can be considered as a variant of a clustered randomised tri...
BackgroundExternal pilot or feasibility studies can be used to estimate key unknown parameters to in...
Researchers routinely compute desired sample sizes of clinical trials to control type-i and type-ii ...
Sample size determination (SSD) is an important aspect of experimental design. In most comparative e...
The objective of non-inferiority trials is to demonstrate the efficiency of a novel treatment whethe...
Sample sizes for randomized controlled trials are typically based on power calculations. They requir...
Simultaneous modelling of dense and sparse pharmacokinetic data is possible with a population approa...
Simulation offers a simple and flexible way to estimate the power of a clinical trial when analytic ...
Background and objectives: A justifiable sample size is essential at trial design stage. Generally t...
While planning clinical trials, when simple formulas are unavailable to calculate sample size, stati...
Abstract Background Estimating the required sample size and statistical power for a study is an inte...
AbstractThe designer of a clinical trial needs to make many assumptions about real-life practice bas...
Basic methods to compute required sample sizes are well understood and supported by widely available...
Determining the optimal sample size is crucial for any scientific investigation. An optimal sample s...
What is the optimal size of an experiment? How should the practical experimenter determine this opti...
BACKGROUND: Stepped wedge trials (SWTs) can be considered as a variant of a clustered randomised tri...
BackgroundExternal pilot or feasibility studies can be used to estimate key unknown parameters to in...
Researchers routinely compute desired sample sizes of clinical trials to control type-i and type-ii ...
Sample size determination (SSD) is an important aspect of experimental design. In most comparative e...
The objective of non-inferiority trials is to demonstrate the efficiency of a novel treatment whethe...
Sample sizes for randomized controlled trials are typically based on power calculations. They requir...
Simultaneous modelling of dense and sparse pharmacokinetic data is possible with a population approa...